mortality/aging
• tamoxifen-treated mice die around 10 days of age probably from fulminant liver failure
|
liver/biliary system
• tamoxifen-treated mice show dilated veins with intrahepatic bleeding
|
• Sirius Red staining, collapsed reticulin fibers, and increased ALT levels in tamoxifen-treated mice indicate that hepatocytes undergo massive apoptosis, leading to liver injury
|
• tamoxifen-treated mice exhibit inflammatory cell infiltration in the liver
|
• tamoxifen-treated mice exhibit disruption of liver tissue architecture, presence of atypia, dilated veins with intrahepatic bleeding, signs of necrosis and inflammatory cell infiltration
|
• in tamoxifen-treated mice
|
homeostasis/metabolism
• tamoxifen-treated mice show increased alanine transaminase (ALT) levels
|
cardiovascular system
• tamoxifen-treated mice show dilated veins with intrahepatic bleeding
|
immune system
• tamoxifen-treated mice exhibit inflammatory cell infiltration in the liver
|
cellular
• Sirius Red staining, collapsed reticulin fibers, and increased ALT levels in tamoxifen-treated mice indicate that hepatocytes undergo massive apoptosis, leading to liver injury
|